ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Airway Therapeutics raised $50 million in funding. The company will use the funds to advance its respiratory disease treatments. The investment supports clinical development of its lead product candidate.
Tap to vote and see what everyone thinks.
Summary by ByteBrief